Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor‐based morphometry

A key question in designing MRI‐based clinical trials is how the main magnetic field strength of the scanner affects the power to detect disease effects. In 110 subjects scanned longitudinally at both 3.0 and 1.5 T, including 24 patients with Alzheimer's Disease (AD) [74.8 ± 9.2 years, MMSE: 22...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Ho, April J., Hua, Xue, Lee, Suh, Leow, Alex D., Yanovsky, Igor, Gutman, Boris, Dinov, Ivo D., Leporé, Natasha, Stein, Jason L., Toga, Arthur W., Jack, Clifford R., Bernstein, Matt A., Reiman, Eric M., Harvey, Danielle J., Kornak, John, Schuff, Norbert, Alexander, Gene E., Weiner, Michael W., Thompson, Paul M.
פורמט: Artigo
שפה:Inglês
יצא לאור: Wiley Subscription Services, Inc., A Wiley Company 2009
נושאים:
Research Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2875376/
https://ncbi.nlm.nih.gov/pubmed/19780044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hbm.20882
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים